The fight against COVID19
23.82k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
Performance
| Watchlist | Change today | 1-month return | 1-year return | Total return |
|---|---|---|---|---|
| The fight against COVID19 | - | - | - | - |
| ^GSPC | -0.21% | +5.47% | +27.37% | +5595.81% |
14 symbols
| Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 154.28 | +1.61 | +1.05% | 16:00 GMT-4 | 6.92M | 7.47M | 371.30B |
| ABBV | AbbVie Inc. | 164.35 | +0.56 | +0.34% | 16:00 GMT-4 | 4.29M | 5.62M | 290.22B |
| PFE | Pfizer Inc. | 28.92 | +0.10 | +0.35% | 16:01 GMT-4 | 34.30M | 42.74M | 163.88B |
| SNY | Sanofi | 48.82 | -0.19 | -0.39% | 16:00 GMT-4 | 1.96M | 2.01M | 122.39B |
| REGN | Regeneron Pharmaceuticals, Inc. | 967.98 | -10.23 | -1.05% | 16:00 GMT-4 | 386.50k | 456.51k | 106.66B |
| GSK | GlaxoSmithKline plc | 44.88 | -0.44 | -0.98% | 16:00 GMT-4 | 3.51M | 3.17M | 94.54B |
| GILD | Gilead Sciences, Inc. | 67.86 | +0.85 | +1.27% | 16:00 GMT-4 | 4.75M | 7.02M | 84.54B |
| MRNA | Moderna, Inc. | 132.68 | +3.62 | +2.80% | 16:00 GMT-4 | 2.93M | 3.84M | 50.85B |
| TAK | Takeda Pharmaceutical Company Limited | 13.31 | -0.08 | -0.60% | 16:00 GMT-4 | 1.19M | 1.66M | 42.07B |
| BNTX | BioNTech SE | 92.98 | +0.78 | +0.85% | 16:00 GMT-4 | 389.05k | 593.01k | 22.41B |
| NVAX | Novavax, Inc. | 14.4 | +1.50 | +11.63% | 16:00 GMT-4 | 24.79M | 12.76M | 2.12B |
| VIR | Vir Biotechnology, Inc. | 9.93 | -0.09 | -0.90% | 16:00 GMT-4 | 395.76k | 993.94k | 1.35B |
| INO | Inovio Pharmaceuticals, Inc. | 12.79 | -0.28 | -2.14% | 16:00 GMT-4 | 365.01k | 444.19k | 331.40M |
Yahoo Finance UKFTSE 100 LIVE: European stocks tepid as UK chancellor sets out more tax cut plans
The FTSE was almost flat as Jeremy Hunt is expected to reiterate his ambition to eradicate the national insurance tax in a speech on Friday.
Evening StandardFTSE 100 Live 17 May: Land Securities results, GSK nets £1.25bn in final Haleon stake sale
GSK and Land Securities are in the FTSE 100 spotlight after the drugs giant sold its final Haleon shares and the property firm posted results. The sale of GSK’s remaining 4% stake raised £1.25 billion, having held 13% following its 2022 demerger of the Panadol and Sensodyne business. Land Securities revealed a smaller full-year loss of £341 million amid “robust” rental growth across its estate.
BloombergGSK to Sell Remaining $1.6 Billion Stake in Haleon
(Bloomberg) -- GSK Plc will sell its remaining stake in Haleon Plc for £1.25 billion ($1.6 billion), completing the drugmaker’s separation from the consumer health company.Most Read from BloombergUS Inflation Data Was Accidentally Released 30 Minutes EarlyWith a BlackRock CEO, $9 Trillion Vanguard Braces for TurbulencePutin and Xi Vow to Step Up Fight to Counter US ‘Containment’Jamie Dimon Sees ‘Lot of Inflationary Forces in Front of Us’Dow Average Touches 40,000 Before Pulling Back: Markets Wra
